Although tau pathology seems to be more strongly correlated with AD-related cognitive dysfunction than Aβ, the Aβ cascade is considered an earlier process, and early intervention preventing Aβ aggregation could help immune dysfunction [53]. The gene discussed is MAPT; the disease is Alzheimer disease.